0
ARTICLE |

EMETIN DIARRHEA —CLINICAL AND EXPERIMENTAL

A. R. KILGORE, M.D.; J. H. LIU, M.D.
Arch Intern Med (Chic). 1917;XX(2):178-183. doi:10.1001/archinte.1917.00090020019003.
Text Size: A A A
Published online

It is well known that, in large doses, emetin hydrochlorid gives rise to a hemorrhagic gastro-enteritis in experimental animals. That it produces a bloody diarrhea not rarely in the course of its clinical use is coming to be recognized, though in an exhaustive review of the literature published last year1 only seven cases were collected. A number of unpublished cases occurring in China have come to our attention through personal communications. It seems to us to present a real danger, well worth more discussion that it has received.

The difficulty in the recognition of diarrhea from emetin, as well as its danger, is due to the fact that it occurs in the course of treatment for amebic dysentery and that the symptoms and the gross appearance of the stools in emetin diarrhea are almost indistinguishable from those in amebic dysentery. The patient receives daily doses of emetin and for a

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs